Consistent with our previous study, both BR2-PPD and BR2-2xPPD peptides significantly inhibited EGF-induced A549 NSCLC cell proliferation, while the mutant PR-PPD peptide failed to affect A549 cell proliferation (Fig 2A and 2B). Here, EGF is linked to non-small cell lung carcinoma.